Potential roles for opioid receptors in motivation and major depressive disorder

被引:25
|
作者
Callaghan, Charlotte K. [1 ]
Rouine, Jennifer [1 ]
O'Mara, Shane M. [1 ]
机构
[1] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin 2, Ireland
关键词
Motivation; Opioids; Dopamine; Depression; Behavior; Nucleus accumbens; Ventral tegmental area; Medial prefrontal cortex; POSTERIOR CINGULATE CORTEX; NUCLEUS-ACCUMBENS SHELL; C-FOS EXPRESSION; FORCED SWIM TEST; DOPAMINE NEURONS; INTERFERON-ALPHA; DOUBLE-BLIND; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX;
D O I
10.1016/bs.pbr.2018.07.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Deficits in motivation are at the core of many neuropsychiatric disorders, including major depressive disorder (MDD). Research in MDD has been heavily focused on anhedonia and depression or negative/ positive symptoms of depression, with less research attention focused on the dysregulation of motivational processes. Opioid receptors are widely distributed throughout the brain, particularly in areas implicated in motivation, especially the striatum, nucleus accumbens, medial prefrontal cortex, hippocampus, ventral tegmental area, hypothalamus, and amygdala. Mu, kappa, and delta opioid receptors (MOR, KOR, and DOR, respectively) and their endogenous ligands play an essential role in the regulation of mood, reward processing, and motivated behavior. This review will highlight the impact of opioids in motivational behavior with a particular focus on depression. An understanding of the neurobiology and neural circuits subserving motivational behavior will facilitate treatment of disorders that comprise reward deficits.
引用
收藏
页码:89 / 119
页数:31
相关论文
共 50 条
  • [1] Histamine and histamine receptors: Roles in major depressive disorder
    Qian, Hong
    Shu, Chang
    Xiao, Ling
    Wang, Gaohua
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [2] Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
    Swardfager, Walter
    Herrmann, Nathan
    McIntyre, Roger S.
    Mazereeuw, Graham
    Goldberger, Kyle
    Cha, Danielle S.
    Schwartz, Yael
    Lanctot, Krista L.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (05): : 911 - 929
  • [3] Evaluation of Opioid Modulation in Major Depressive Disorder
    Elliot Ehrich
    Ryan Turncliff
    Yangchun Du
    Richard Leigh-Pemberton
    Emilio Fernandez
    Reese Jones
    Maurizio Fava
    Neuropsychopharmacology, 2015, 40 : 1448 - 1455
  • [4] Evaluation of Opioid Modulation in Major Depressive Disorder
    Ehrich, Elliot
    Turncliff, Ryan
    Du, Yangchun
    Leigh-Pemberton, Richard
    Fernandez, Emilio
    Jones, Reese
    Fava, Maurizio
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (06) : 1448 - 1455
  • [5] The roles of extracellular vesicles in major depressive disorder
    Li, Ying
    Gui, Yan
    Zhao, Miaomiao
    Chen, Xuanqiang
    Li, Haimei
    Tian, Chen
    Zhao, Haoyang
    Jiang, Chaonan
    Xu, Pengfeng
    Zhang, Shiyi
    Ye, Shaoyong
    Huang, Manli
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [6] Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder
    Hampsey, Elliot
    Jelen, Luke
    Young, Allan H.
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (03) : 193 - 204
  • [7] Potential Roles of m6A and FTO in Synaptic Connectivity and Major Depressive Disorder
    Mitsuhashi, Haruka
    Nagy, Corina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [8] Motivation System Impairment Profiles in Schizophrenia and Major Depressive Disorder
    Da Silva, Susana
    Saperia, Sarah
    Siddiqui, Ishraq
    Agid, Ofer
    Voineskos, Aristotle
    Daskalakis, Jeff
    Ravindran, Arun
    Zakzanis, Konstantine
    Remington, Gary
    Foussias, George
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S338 - S338
  • [9] Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
    Jaso, Brittany A.
    Niciu, Mark J.
    Iadarola, Nicolas D.
    Lally, Niall
    Richards, Erica M.
    Park, Minkyung
    Ballard, Elizabeth D.
    Nugent, Allison C.
    Machado-Vieira, Rodrigo
    Zarate, Carlos A., Jr.
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (01) : 57 - 70
  • [10] The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD)
    Yang, Kai
    Wang, Changcai
    Sun, Taolei
    FRONTIERS IN PHARMACOLOGY, 2019, 10